These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21196155)

  • 1. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.
    Das UN; Repossi G; Dain A; Eynard AR
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):13-20. PubMed ID: 21196155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y; Lei M; Fu S; Fu Y
    Life Sci; 2005 May; 77(2):149-59. PubMed ID: 15862600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
    Triches CB; Mayer S; Quinto BMR; Batista MC; Zanella MT
    J Clin Hypertens (Greenwich); 2018 May; 20(5):935-941. PubMed ID: 29604155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients.
    Sciacqua A; Grillo N; Quero M; Sesti G; Perticone F
    Int J Mol Sci; 2012 Oct; 13(11):13804-15. PubMed ID: 23203035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Galiano Leone G; Bruni R; Di Cello S; Pascale A; Talarico G; Greco L; Andreozzi F; Sesti G
    Int J Cardiol; 2010 Jul; 142(3):236-41. PubMed ID: 19168237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
    Stühlinger M
    Wien Med Wochenschr; 2007 Feb; 157(3-4):57-60. PubMed ID: 17340060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
    Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
    Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Circ J; 2002 Sep; 66(9):811-5. PubMed ID: 12224817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs.
    Peng H; Chen L; Huang X; Yang T; Yu Z; Cheng G; Zhang G; Shi R
    J Am Soc Hypertens; 2016 Sep; 10(9):741-751.e3. PubMed ID: 27475679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes.
    Pleiner J; Mittermayer F; Langenberger H; Winzer C; Schaller G; Pacini G; Kautzky-Willer A; Tura A; Wolzt M
    Wien Klin Wochenschr; 2007; 119(15-16):483-9. PubMed ID: 17721768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
    Böger RH; Schwedhelm E; Maas R; Quispe-Bravo S; Skamira C
    Vasc Med; 2005 Jul; 10 Suppl 1():S97-102. PubMed ID: 16444875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus.
    Gajecki D; Gawryś J; Wiśniewski J; Fortuna P; Szahidewicz-Krupska E; Doroszko A
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.